Clinical Trial Update: Noninvasive Modulation of Chronic Neuropathic Pain [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating noninvasive modulation of chronic neuropathic pain has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuropathic Pain
• Pain

Snippet

Sponsor: University of Utah | Conditions: Neuropathic Pain, Chronic Pain | Phase 1, Phase 2 | Status: WITHDRAWN